Felix Capital invests in Medly AI
Funding Provisional 95% confidence first seen
Felix Capital led an $8 million seed funding round for UK edtech startup Medly AI, which provides AI-powered exam tutoring using seven large language models combined with neuroscience-informed approaches. The round also included participation from existing investors Eka Ventures and Ada Ventures, as well as several angel investors. The funding will support Medly's expansion across the UK and internationally, including recent launches in the US for SAT preparation.
The deal
Medly AI $8M Seed · announced 19 Aug 2026
Investors Felix Capital
Deal terms as reported in the coverage below.
Decision brief
- What changed
- UK edtech startup Medly AI raised an $8 million seed round led by Felix Capital, with participation from Eka Ventures, Ada Ventures, and angel investors, to expand its AI-powered exam tutoring platform in the UK and internationally, including a recent US SAT-prep launch.
- Why it matters
- This signals continued investor appetite for AI-native edtech tools that combine multiple LLMs with pedagogical design, at a time when consumer AI tutoring is scaling rapidly (400,000+ UK users since a February 2025 launch). For education, edtech, and consumer AI executives, Medly's approach—using seven LLMs plus neuroscience-informed methods—offers a competitive template worth tracking as international expansion (notably into the US SAT market) tests whether UK-born AI tutoring models can compete with established US players.
- Evidence
- The only source is a single Tech.eu article; funding amount, investor list, user numbers, and expansion plans are stated without independent corroboration from other outlets.
- What remains uncertain
- It's unclear how the seven-LLM architecture translates into measurable learning outcomes versus marketing claims, and no financial details (valuation, revenue, unit economics) are disclosed. The single-source coverage means claims about user base size and international traction are unverified beyond the company's own reporting.
- Monitor next
- Watch for Medly AI's US market traction (SAT prep adoption/user growth) and whether additional funding rounds or independent press coverage validate the stated UK user base and expansion claims.
Analytical support, not advice — assumptions and open questions stated above.